Evidence map›Paper›PMID 29972022›Full record

ArticleACS applied materials & interfaces2018

Superhydrophobic Photosensitizers: Airborne

Smruti Pushalkar, Goutam Ghosh, QianFeng Xu, Yang Liu, Ashwini A Ghogare, Cecilia Atem, Alexander Greer, Deepak Saxena, Alan M Lyons

Abstract read
In one paragraph

Article in ACS applied materials & interfaces, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Perfluorocarbon nanomaterials for photodynamic therapy.Current opinion in colloid & interface science · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Smruti PushalkarDepartment of Basic Sciences and Craniofacial Biology , New York University College of Dentistry , New York 10010 , United States.
Goutam GhoshDepartment of Chemistry , Brooklyn College, City University of New York , Brooklyn , New York 11210 , United States.
QianFeng XuSingletO2 Therapeutics LLC , 215 W 125th Street, 4th Floor , New York , New York 10027 , United States.
Yang LiuDepartment of Chemistry, College of Staten Island , City University of New York , Staten Island , New York 10314 , United States.ORCID http://orcid.org/0000-0003-4978-6051
Ashwini A GhogareDepartment of Chemistry , Brooklyn College, City University of New York , Brooklyn , New York 11210 , United States.
Cecilia AtemDepartment of Basic Sciences and Craniofacial Biology , New York University College of Dentistry , New York 10010 , United States.
Alexander GreerDepartment of Chemistry , Brooklyn College, City University of New York , Brooklyn , New York 11210 , United States.ORCID http://orcid.org/0000-0003-4444-9099
Deepak SaxenaDepartment of Basic Sciences and Craniofacial Biology , New York University College of Dentistry , New York 10010 , United States.ORCID http://orcid.org/0000-0002-5506-5827
Alan M LyonsDepartment of Chemistry, College of Staten Island , City University of New York , Staten Island , New York 10314 , United States.
The Graduate Center, CUNY · USNew York University · USCity University of New York · US

Funding

Superhydrophobic Implantable Surface and 3D Printing Technology for Targeted Dental Photodynamic TherapyR41DE026083 · NIDCR · SINGLETO2 THERAPEUTICS, LLC · PI GREER, ALEXANDER · 2016 to 2017
$225k
NIDCR NIH HHS R41 DE026083
6 · The paper itself

Abstract

Singlet oxygen is a potent agent for the selective killing of a wide range of harmful cells; however, current delivery methods pose significant obstacles to its widespread use as a treatment agent. Limitations include the need for photosensitizer proximity to tissue because of the short (3.5 μs) lifetime of singlet oxygen in contact with water; the strong optical absorption of the photosensitizer, which limits the penetration depth; and hypoxic environments that restrict the concentration of available oxygen. In this article, we describe a novel superhydrophobic singlet oxygen delivery device for the selective inactivation of bacterial biofilms. The device addresses the current limitations by: immobilizing photosensitizer molecules onto inert silica particles; embedding the photosensitizer-containing particles into the plastron (i.e. the fluid-free space within a superhydrophobic surface between the solid substrate and fluid layer); distributing the particles along an optically transparent substrate such that they can be uniformly illuminated; enabling the penetration of oxygen via the contiguous vapor space defined by the plastron; and stabilizing the superhydrophobic state while avoiding the direct contact of the sensitizer to biomaterials. In this way, singlet oxygen generated on the sensitizer-containing particles can diffuse across the plastron and kill bacteria even deep within the hypoxic periodontal pockets. For the first time, we demonstrate complete biofilm inactivation (>5 log killing) of Porphyromonas gingivalis, a bacterium implicated in periodontal disease using the superhydrophobic singlet oxygen delivery device. The biofilms were cultured on hydroxyapatite disks and exposed to active and control surfaces to assess the killing efficiency as monitored by colony counting and confocal microscopy. Two sensitizer particle types, a silicon phthalocyanine sol-gel and a chlorin e6 derivative covalently bound to fluorinated silica, were evaluated; the biofilm killing efficiency was found to correlate with the amount of singlet oxygen detected in separate trapping studies. Finally, we discuss the applications of such devices in the treatment of periodontitis.

Indexed as

BiofilmsOxygenPhotochemotherapyPhotosensitizing AgentsSilicon DioxideSinglet OxygenOxygenPhotosensitizing AgentsSilicon DioxideSinglet Oxygenbiofilm eradicationdentistryphotodynamic therapysinglet oxygensuperhydrophobic device

Identifiers

PMID29972022
PMCPMC6698391
OpenAlexW2810545318

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.